Combination of Intrathecal Opioids with Bupivacaine Attenuates Opioid Dose Escalation in Chronic Noncancer Pain Patients

Pain Medicine

Volumn 12, Issue 10, 2011, Pages 1481-1489

  Veizi, I Elias ^a   Hayek, Salim M ^a   Narouze, Samer ^d   Pope, Jason E ^b   Mekhail, Nagy ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Napa Pain Institute   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Summa Western Reserve Hospital   (United States)

Author keywords

Bupivacaine; Chronic Low Back Pain; Intrathecal; Local Anesthetics; Opioids; Postlaminectomy Syndrome

Indexed keywords

BUPIVACAINE; CLONIDINE; HYDROMORPHONE; MORPHINE SULFATE; OMEGA CONOTOXIN MVIIA;

ADULT; ANALGESIA; ARTICLE; BONE PAIN; CHRONIC PAIN; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG USE; FEMALE; HUMAN; INTERVENTION STUDY; INTRACTABLE PAIN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; OSTEOPOROSIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PHYSICIAN; POSTHERPETIC NEURALGIA; RETROSPECTIVE STUDY; SPINAL CORD DISEASE; TERTIARY HEALTH CARE; VERTEBRA FRACTURE; VISCERAL PAIN;

EID: 80255132674     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01232.x     Document Type: Article

References (37)

1. Hassenbusch SJ, Portenoy RK, Cousins M, etal. Polyanalgesic Consensus Conference 2003: An update on the management of pain by intraspinal drug delivery-report of an expert panel. J Pain Symptom Manage 2004;27(6):540-63.
2. Smith TJ, Staats PS, Deer T, etal. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20(19):4040-9.
3. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology 1984;61(3):276-310.
4. Deer TR, Smith HS, Cousins M, etal. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician 2010;13(3):E175-213.
5. Bernards CM. Understanding the physiology and pharmacology of epidural and intrathecal opioids. Best Pract Res Clin Anaesthesiol 2002;16(4):489-505.
6. Roberts LJ, Finch PM, Goucke CR, Price LM. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain 2001;5(4):353-61.
7. Atli A, Theodore BR, Turk DC, Loeser JD. Intrathecal opioid therapy for chronic nonmalignant pain: A retrospective cohort study with 3-year follow-up. Pain Med 2010;11(7):1010-6.
8. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: Long-term benefits and efficacy. Surg Neurol 2001;55(2):79-86.
9. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: A retrospective, multicenter study. J Pain Symptom Manage 1996;11(2):71-80.
10. Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP. Age-dependent opioid escalation in chronic pain patients. Anesth Analg 2005;100(6):1740-5.
11. Rauck RL, Cherry D, Boyer MF, etal. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 2003;4(8):441-7.
12. Allen JW, Horais KA, Tozier NA, Yaksh TL. Opiate pharmacology of intrathecal granulomas. Anesthesiology 2006;105(3):590-8.
13. Deer TR. A prospective analysis of intrathecal granuloma in chronic pain patients: A review of the literature and report of a surveillance study. Pain Physician 2004;7(2):225-8.
14. Singla A, Stojanovic MP, Chen L, Mao J. A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion. Anesth Analg 2007;105(6):1816-9. table of contents.
15. Deer T, Krames ES, Hassenbusch SJ, etal. Polyanalgesic Consensus Conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromudulation: Technol Neural Interface 2007;10(4):300-28.
16. Tejwani GA, Rattan AK, McDonald JS. Role of spinal opioid receptors in the antinociceptive interactions between intrathecal morphine and bupivacaine. Anesth Analg 1992;74(5):726-34.
17. Penning JP, Yaksh TL. Interaction of intrathecal morphine with bupivacaine and lidocaine in the rat. Anesthesiology 1992;77(6):1186-2000.
18. Siti Salmah G, Choy YC. Comparison of morphine with fentanyl added to intrathecal 0.5% hyperbaric bupivacaine for analgesia after caesarean section. Med J Malaysia 2009;64(1):71-4.
19. Adrian JR, Sanz Lipuzcoa J, Sanz Fernandez J, etal. A bupivacaine-morphine combination by intrathecal route: Correlation between pain relief and postoperative neuroendocrine response. Rev Med Univ Navarra 1988;32(1):35-9.
20. Cohen SP, Dragovich A. Intrathecal analgesia. Anesthesiol Clin 2007;25(4):863-82. viii.
21. Dominguez E, Sahinler B, Bassam D, etal. Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain patients. Pain Pract 2002;2(4):315-25.
22. Rainov NG, Heidecke V, Burkert W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001;22(4):862-71.
23. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85(3):458-67.
24. Shaladi A, Saltari MR, Piva B, etal. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis. Clin J Pain 2007;23(6):511-7.
25. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: A 3-year prospective study. Pain 2004;109(3):242-9.
26. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44(2):289-300.
27. Njee T, Irthum B, Roussel PH, Peragut J. Intrathecal morphine infusion for chronic non-malignant pain: A multiple center retrospective survey. Neuromodulation 2004;7(4):249-59.
28. Lund C, Selmar P, Hansen OB, Kehlet H. Effect of intrathecal bupivacaine on somatosensory evoked potentials following dermatomal stimulation. Anesth Analg 1987;66(9):809-13.
29. Maves TJ, Gebhart GF. Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat. Anesthesiology 1992;76(1):91-9.
30. Ingram SL, Williams JT. Opioid inhibition of Ih via adenylyl cyclase. Neuron 1994;13(1):179-86.
31. Sugiyama K, Muteki T. Local anesthetics depress the calcium current of rat sensory neurons in culture. Anesthesiology 1994;80(6):1369-78.
32. Deer TR, Caraway DL, Kim CK, etal. Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. Spine J 2002;2(4):274-8.
33. Hildebrand KR, Elsberry DD, Deer TR. Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system. Clin J Pain 2001;17(3):239-44.
34. Mironer YEHJ, Chapple I, Brown CH, Satterthwaite JR. Efficacy and safety of intrathecal opioid/bupivacaine mixture in chronic nonmalignant pain: A double blind, randomized, crossover, multicenter study by the National Forum of Independent Pain Clinicians (NFIPC). 2002.
35. Kumar K, Bodani V, Bishop S, Tracey S. Use of intrathecal bupivacaine in refractory chronic nonmalignant pain. Pain Med 2009;10(5):819-28.
36. Buchser E, Durrer A, Chedel D, Mustaki JP. Efficacy of intrathecal bupivacaine: How important is the flow rate? Pain Med 2004;5(3):248-52.
37. van Dongen RT, Crul BJ, van Egmond J. Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin J Pain 1999;15(3):166-72.